Mark Stacy

14.7k total citations · 2 hit papers
110 papers, 8.0k citations indexed

About

Mark Stacy is a scholar working on Neurology, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, Mark Stacy has authored 110 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Neurology, 30 papers in Cellular and Molecular Neuroscience and 12 papers in Cognitive Neuroscience. Recurrent topics in Mark Stacy's work include Parkinson's Disease Mechanisms and Treatments (75 papers), Neurological disorders and treatments (74 papers) and Botulinum Toxin and Related Neurological Disorders (30 papers). Mark Stacy is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (75 papers), Neurological disorders and treatments (74 papers) and Botulinum Toxin and Related Neurological Disorders (30 papers). Mark Stacy collaborates with scholars based in United States, Canada and United Kingdom. Mark Stacy's co-authors include Joseph Jankovic, Daniel Weintraub, Anthony E. Lang, Valerie Voon, Marc N. Potenza, Glen Wunderlich, Jacqueline Whetteckey, Andrew Siderowf, Ariane Park and Juergen Koester and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Annals of Neurology.

In The Last Decade

Mark Stacy

109 papers receiving 7.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impulse Control Disorders in Parkinson Disease

2010 971 citations Daniel Weintraub, Marc N. Potenza et al. profile →
Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD

2003 622 citations Cynthia Comella, Joseph Jankovic et al. profile →

Peers

Countries citing papers authored by Mark Stacy

Since Specialization

Citations

This map shows the geographic impact of Mark Stacy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Stacy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Stacy more than expected).

Fields of papers citing papers by Mark Stacy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Stacy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Stacy. The network helps show where Mark Stacy may publish in the future.

Co-authorship network of co-authors of Mark Stacy

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Stacy. A scholar is included among the top collaborators of Mark Stacy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Stacy. Mark Stacy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Healing in relationships, the power of equine-assisted mental health interventions 2025 ·Journal of Social Work Practice ·Mark Stacy, (unknown)	0
2	The spectrum of “off” in Parkinson's disease: What have we learned over 40 years? 2018 ·Parkinsonism & Related Disorders ·Kelvin L. Chou, Mark Stacy, Tanya Simuni, Janis M. Miyasaki, Wolfgang H. Oertel, Kapil D. Sethi, Hubert H. Fernandez, Fabrizio Stocchi	119
3	Cervical dystonia and pain: characteristics and treatment patterns from CD PROBE (Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy) 2014 ·Journal of Neurology ·David Charles, Charles H. Adler, Mark Stacy, Cynthia Comella, Joseph Jankovic, Aubrey Manack Adams, Marc Schwartz, Mitchell F. Brin	63
4	Primary results from the Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy (CD PROBE) 2014 ·Journal of the Neurological Sciences ·Joseph Jankovic, Charles H. Adler, David Charles, Cynthia Comella, Mark Stacy, Marc Schwartz, Aubrey Manack Adams, Mitchell F. Brin	58
5	PND11 Cost of Cervical Dystonia in the United States 2012 ·Value in Health ·Lisa Bloudek, Mark Stacy, (unknown), Mitchell F. Brin, Spyridon Papapetropoulos	3
6	New triggers and non-motor findings in a family with rapid-onset dystonia-parkinsonism 2012 ·Parkinsonism & Related Disorders ·Richard L. Barbano, (unknown), Beverly M. Snively, Laney S. Light, Niki Boggs, W. Vaughn McCall, Mark Stacy, Laurie J. Ozelius, Kathleen J. Sweadner, Allison Brashear	26
7	Impulse control disorders in parkinson disease: A multicenter case–control study 2011 ·Annals of Neurology ·Valerie Voon, Mandy Sohr, Anthony E. Lang, Marc N. Potenza, Andrew Siderowf, Jacqueline Whetteckey, Daniel Weintraub, Glen Wunderlich, Mark Stacy	284
8	Wearing‐off scales in Parkinson's disease: Critique and recommendations 2011 ·Movement Disorders ·Angelo Antonini, Pablo Martínez‐Martín, К. Ray Chaudhuri, Marcelo Merello, Robert A. Hauser, Regina Katzenschlager, Per Odin, Mark Stacy, Fabrizio Stocchi, Werner Poewe, Oliver Rascol, Cristina Sampaio, Anette Schrag, Glenn T. Stebbins, Christopher G. Goetz	102
9	Amantadine use associated with impulse control disorders in Parkinson disease in cross‐sectional study 2010 ·Annals of Neurology ·Daniel Weintraub, Mandy Sohr, Marc N. Potenza, Andrew Siderowf, Mark Stacy, Valerie Voon, Jacqueline Whetteckey, Glen Wunderlich, Anthony E. Lang	114
10	Clinical features of patients with blepharospasm: a report of 240 patients 2010 ·European Journal of Neurology ·Elizabeth Peckham, (unknown), Ejaz A. Shamim, (unknown), (unknown), Roneil G. Malkani, Mark Stacy, (unknown), Anthony Crawley, Amanda Singleton, Mark Hallett	47
11	Impulsive and compulsive behaviors in Parkinson's disease 2009 ·Movement Disorders ·Andrew Evans, Antonio P. Strafella, Daniel Weintraub, Mark Stacy	173
12	Medical Treatment of Parkinson Disease 2009 ·Neurologic Clinics ·Mark Stacy	29
13	The sensitivity and specificity of the 9-item Wearing-off Questionnaire 2007 ·Parkinsonism & Related Disorders ·Mark Stacy, Murphy Jm, David Greeley, R. Malcolm Stewart, Harald Murck, (unknown)	60
14	Apomorphine for the acute treatment of “off” episodes in Parkinson's disease 2007 ·Parkinsonism & Related Disorders ·Mark Stacy, Dee E. Silver	36
15	Medication adherence and associated outcomes in medicare health maintenance organization‐enrolled older adults with Parkinson's disease 2007 ·Movement Disorders ·Amit S. Kulkarni, Rajesh Balkrishnan, Roger T. Anderson, Heather M. Edin, (unknown), Mark Stacy	88
16	Development of a Patient Questionnaire to facilitate recognition of motor and non-motor wearing-off in Parkinson’s disease 2006 ·Journal of Neural Transmission ·Mark Stacy, Robert A. Hauser	67
17	Physiology and pathophysiology of cortico-basal ganglia–thalamocortical loops: Theoretical and practical aspects 2002 ·Progress in Neuro-Psychopharmacology and Biological Psychiatry ·K. V. Baev, Karl A. Greene, Frederick F. Marciano, Johan Samanta, Andrew G. Shetter, Kris A. Smith, Mark Stacy, Robert F. Spetzler	28
18	MANAGING LATE COMPLICATIONS OF PARKINSON'S DISEASE 1999 ·Medical Clinics of North America ·Mark Stacy	12
19	COMPARISON OF TWO INJECTION TECHNIQUES USING BOTULINUM TOXIN IN SPASTIC HEMIPLEGIA1 1996 ·American Journal of Physical Medicine & Rehabilitation ·Martin K. Childers, Mark Stacy, Daniel L. Cooke, Henry H. Stonnington	51
20	An Open-Labelled Assessment of Adverse Effects Associated with Interferon 1-Beta in the Treatment of Multiple Sclerosis 1995 ·Journal of Neuroscience Nursing ·(unknown), Mark Stacy	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact